- CNW Group•26 days ago
GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results
- PR Newswire•26 days ago
TORONTO, April 3, 2017 /CNW/ - GeneNews Limited (GEN.TO) ("GeneNews" or the "Company") today announced operational and financial results for the three-month and full year periods ended December 31, 2016. "2016 was a pivotal year for GeneNews. Through the buyout of IDL in May 2015 and March 2016, we were able to establish full control of the laboratory, allowing for the refinancing of GeneNews and the new focus on positioning our early cancer diagnostic tests in the risk stratification of patients so that those at highest risk are prioritized for advanced diagnosis and treatment," commented James R Howard-Tripp, GeneNews' Chairman and CEO.
- Accesswire•last month
Research Reports Initiated on Healthcare Stocks Spectral Medical, GeneNews, Novadaq Technologies, and ProMIS Neurosciences
LONDON, UK / ACCESSWIRE / March 30, 2017 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected ...
GEN.TO : Summary for GENENEWS LIMITED - Yahoo Finance
GeneNews Limited (GEN.TO)
Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||0.30 - 0.31|
|52 Week Range||0.14 - 0.57|
|PE Ratio (TTM)||-3.33|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|